Merck & Co MRK
$146.73 −$0.21 (-0.14%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $146.73 0.00%
Open$144.34
Prev close$146.94
Day range$142.80 – $147.48
Volume7.63M
Market cap$361.73B
P/E (TTM)148.2
Dividend yield2.32%
MRK Stock News
Headlines matching Merck & Co or the MRK ticker, most recent first.
- Wells Fargo Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 Positive
- RBC Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $150
- BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $166
- Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
- OKX announced the listing of five tokens, including MRK perpetual contracts, WMT perpetual contracts, and MARA perpetual contracts.
- Argus Research Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 Positive
- Wolfe Research Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180 Positive
- Leerink Partners Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $161 Positive
- Barclays Downgrades Merck & Co(MRK.US) to Hold Rating, Raises Target Price to $174.46 Mixed
- Guggenheim Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 Positive
- Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180 Positive
- BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $170
- Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)
- UBS Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $175
- BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $166
No comments yet — be the first to weigh in on MRK.
Sign in to join the discussion.